Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.06432313 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.53715871 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.53715871 |
4 | modulation by symbiont of host immune response (GO:0052553) | 4.53715871 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.53715871 |
6 | modulation by symbiont of host defense response (GO:0052031) | 4.53715871 |
7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.53715871 |
8 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.37358421 |
9 | ribosomal small subunit assembly (GO:0000028) | 4.30566049 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.17618133 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17618133 |
12 | viral transcription (GO:0019083) | 3.91210400 |
13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.80335188 |
14 | DNA deamination (GO:0045006) | 3.76111958 |
15 | translational termination (GO:0006415) | 3.75346860 |
16 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.56404142 |
17 | negative regulation of interleukin-12 production (GO:0032695) | 3.56346534 |
18 | regulation of mast cell degranulation (GO:0043304) | 3.55425195 |
19 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.49762520 |
20 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.39226131 |
21 | protein targeting to ER (GO:0045047) | 3.38198196 |
22 | response to interferon-beta (GO:0035456) | 3.37392462 |
23 | cotranslational protein targeting to membrane (GO:0006613) | 3.36036950 |
24 | translational elongation (GO:0006414) | 3.33093034 |
25 | detection of other organism (GO:0098543) | 3.32651951 |
26 | macrophage activation involved in immune response (GO:0002281) | 3.30157144 |
27 | negative regulation of phagocytosis (GO:0050765) | 3.25444703 |
28 | response to host immune response (GO:0052572) | 3.24744972 |
29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.24744972 |
30 | protein localization to endoplasmic reticulum (GO:0070972) | 3.24454618 |
31 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21905695 |
32 | immunoglobulin mediated immune response (GO:0016064) | 3.20004958 |
33 | positive regulation of mast cell activation (GO:0033005) | 3.19657195 |
34 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.19058090 |
35 | detection of bacterium (GO:0016045) | 3.18661141 |
36 | positive regulation of mast cell degranulation (GO:0043306) | 3.17821324 |
37 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.17821324 |
38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.16424552 |
39 | regulation of mast cell activation (GO:0033003) | 3.11756920 |
40 | actin nucleation (GO:0045010) | 3.11488937 |
41 | viral life cycle (GO:0019058) | 3.09312772 |
42 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.08199322 |
43 | translational initiation (GO:0006413) | 2.99890214 |
44 | amino sugar catabolic process (GO:0046348) | 2.98742294 |
45 | pentose-phosphate shunt (GO:0006098) | 2.98054257 |
46 | cellular response to interferon-beta (GO:0035458) | 2.97381710 |
47 | B cell mediated immunity (GO:0019724) | 2.97355233 |
48 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.96898650 |
49 | neutrophil activation (GO:0042119) | 2.95661967 |
50 | regulation of leukocyte degranulation (GO:0043300) | 2.95616679 |
51 | cellular extravasation (GO:0045123) | 2.94818675 |
52 | positive regulation of antigen processing and presentation (GO:0002579) | 2.92099758 |
53 | response to host (GO:0075136) | 2.91780081 |
54 | response to host defenses (GO:0052200) | 2.91780081 |
55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91780081 |
56 | granulocyte activation (GO:0036230) | 2.91148258 |
57 | amyloid precursor protein catabolic process (GO:0042987) | 2.90472614 |
58 | response to interferon-alpha (GO:0035455) | 2.90005428 |
59 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.89786633 |
60 | detection of external biotic stimulus (GO:0098581) | 2.87118991 |
61 | endosome to pigment granule transport (GO:0043485) | 2.86998502 |
62 | endosome to melanosome transport (GO:0035646) | 2.86998502 |
63 | formation of translation preinitiation complex (GO:0001731) | 2.86402193 |
64 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.85629612 |
65 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.85118155 |
66 | glycosphingolipid catabolic process (GO:0046479) | 2.81432859 |
67 | maturation of SSU-rRNA (GO:0030490) | 2.81380344 |
68 | positive regulation of interferon-alpha production (GO:0032727) | 2.80875804 |
69 | NADPH regeneration (GO:0006740) | 2.80539114 |
70 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.80399805 |
71 | microglial cell activation (GO:0001774) | 2.80098482 |
72 | phagosome maturation (GO:0090382) | 2.79963333 |
73 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.78250218 |
74 | ribosomal small subunit biogenesis (GO:0042274) | 2.77200004 |
75 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.77136579 |
76 | barbed-end actin filament capping (GO:0051016) | 2.77026939 |
77 | pentose metabolic process (GO:0019321) | 2.75744200 |
78 | positive regulation of lamellipodium assembly (GO:0010592) | 2.75649406 |
79 | cellular protein complex disassembly (GO:0043624) | 2.74202093 |
80 | response to type I interferon (GO:0034340) | 2.72772877 |
81 | detection of molecule of bacterial origin (GO:0032490) | 2.72213419 |
82 | type I interferon signaling pathway (GO:0060337) | 2.72039408 |
83 | cellular response to type I interferon (GO:0071357) | 2.72039408 |
84 | myeloid cell activation involved in immune response (GO:0002275) | 2.71925685 |
85 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70836559 |
86 | autophagic vacuole fusion (GO:0000046) | 2.70679904 |
87 | cellular response to zinc ion (GO:0071294) | 2.69412492 |
88 | base-excision repair, AP site formation (GO:0006285) | 2.68960881 |
89 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.68906399 |
90 | deoxyribonucleotide catabolic process (GO:0009264) | 2.68750668 |
91 | ribosomal large subunit biogenesis (GO:0042273) | 2.68552892 |
92 | negative regulation of B cell apoptotic process (GO:0002903) | 2.67497927 |
93 | regulation of hypersensitivity (GO:0002883) | 2.67110746 |
94 | negative regulation of cell killing (GO:0031342) | 2.66632471 |
95 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.66632471 |
96 | regulation of protein heterodimerization activity (GO:0043497) | 2.66535888 |
97 | neutrophil activation involved in immune response (GO:0002283) | 2.65902122 |
98 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.65853817 |
99 | macrophage activation (GO:0042116) | 2.64798645 |
100 | platelet dense granule organization (GO:0060155) | 2.64345077 |
101 | regulation of interferon-alpha production (GO:0032647) | 2.63293223 |
102 | reactive oxygen species biosynthetic process (GO:1903409) | 2.62346444 |
103 | deoxyribose phosphate catabolic process (GO:0046386) | 2.60946705 |
104 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.58815893 |
105 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.58245507 |
106 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.58169811 |
107 | glycolipid catabolic process (GO:0019377) | 2.57396324 |
108 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.57294199 |
109 | neutrophil mediated immunity (GO:0002446) | 2.56736892 |
110 | regulation of B cell apoptotic process (GO:0002902) | 2.56334746 |
111 | positive regulation of leukocyte degranulation (GO:0043302) | 2.56145120 |
112 | detection of biotic stimulus (GO:0009595) | 2.56134383 |
113 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.55107987 |
114 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.54078054 |
115 | positive regulation of regulated secretory pathway (GO:1903307) | 2.53461457 |
116 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.53413549 |
117 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.52660086 |
118 | oligosaccharide catabolic process (GO:0009313) | 2.52480333 |
119 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.52313208 |
120 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.50439987 |
121 | regulation of regulated secretory pathway (GO:1903305) | 2.49771689 |
122 | regulation of response to interferon-gamma (GO:0060330) | 2.48904082 |
123 | negative regulation of granulocyte differentiation (GO:0030853) | 2.47298613 |
124 | lysosome organization (GO:0007040) | 2.47026447 |
125 | lytic vacuole organization (GO:0080171) | 2.47026447 |
126 | polyketide metabolic process (GO:0030638) | 2.46274253 |
127 | doxorubicin metabolic process (GO:0044598) | 2.46274253 |
128 | daunorubicin metabolic process (GO:0044597) | 2.46274253 |
129 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.45066819 |
130 | defense response to protozoan (GO:0042832) | 2.45032377 |
131 | leukocyte degranulation (GO:0043299) | 2.43711810 |
132 | response to xenobiotic stimulus (GO:0009410) | 2.43676344 |
133 | protein complex disassembly (GO:0043241) | 2.42266972 |
134 | regulation of superoxide anion generation (GO:0032928) | 2.42207862 |
135 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.42178868 |
136 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.41766383 |
137 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.41766383 |
138 | sequestering of actin monomers (GO:0042989) | 2.41230828 |
139 | response to peptidoglycan (GO:0032494) | 2.40771989 |
140 | purine-containing compound salvage (GO:0043101) | 2.39815880 |
141 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.39540807 |
142 | regulation of monocyte differentiation (GO:0045655) | 2.38955887 |
143 | negative regulation of interleukin-6 production (GO:0032715) | 2.38791572 |
144 | DNA strand elongation (GO:0022616) | 2.38499508 |
145 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.37500809 |
146 | ceramide catabolic process (GO:0046514) | 2.36646848 |
147 | glycoside metabolic process (GO:0016137) | 2.35932403 |
148 | respiratory burst (GO:0045730) | 2.34712900 |
149 | telomere maintenance via recombination (GO:0000722) | 2.32906178 |
150 | pinocytosis (GO:0006907) | 2.32603933 |
151 | response to protozoan (GO:0001562) | 2.31954680 |
152 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.31527300 |
153 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.29960628 |
154 | protein targeting to membrane (GO:0006612) | 2.28580989 |
155 | translation (GO:0006412) | 2.27702511 |
156 | positive regulation of lamellipodium organization (GO:1902745) | 2.27341749 |
157 | positive regulation of B cell differentiation (GO:0045579) | 2.27158796 |
158 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.26740298 |
159 | macromolecular complex disassembly (GO:0032984) | 2.26452556 |
160 | leukocyte aggregation (GO:0070486) | 2.25996504 |
161 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.25800967 |
162 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.21929308 |
163 | NIK/NF-kappaB signaling (GO:0038061) | 2.21422339 |
164 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.19516731 |
165 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.19199188 |
166 | signal peptide processing (GO:0006465) | 2.18528103 |
167 | DNA replication initiation (GO:0006270) | 2.18432495 |
168 | regulation of B cell differentiation (GO:0045577) | 2.17038928 |
169 | positive regulation of interferon-beta production (GO:0032728) | 2.16705587 |
170 | proteasome assembly (GO:0043248) | 2.16597325 |
171 | muscle organ morphogenesis (GO:0048644) | 2.16561785 |
172 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.16015333 |
173 | macrophage differentiation (GO:0030225) | 2.15768490 |
174 | T cell apoptotic process (GO:0070231) | 2.15128765 |
175 | Golgi transport vesicle coating (GO:0048200) | 2.14315057 |
176 | COPI coating of Golgi vesicle (GO:0048205) | 2.14315057 |
177 | regulation of antigen processing and presentation (GO:0002577) | 2.12908106 |
178 | morphogenesis of an endothelium (GO:0003159) | 2.12540000 |
179 | endothelial tube morphogenesis (GO:0061154) | 2.12540000 |
180 | dendritic cell differentiation (GO:0097028) | 2.11716207 |
181 | phospholipid scrambling (GO:0017121) | 2.09827950 |
182 | regulation of necroptotic process (GO:0060544) | 2.09708957 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.35998718 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.35258213 |
3 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.98857546 |
4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.80064414 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.59302639 |
6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53161200 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.46751917 |
8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.40085463 |
9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.35746338 |
10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.34028709 |
11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.22996453 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.21263750 |
13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.21063336 |
14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15263995 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.10552825 |
16 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09697092 |
17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04373645 |
18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.00073218 |
19 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.97774849 |
20 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.93968936 |
21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.91654197 |
22 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.88779224 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87841978 |
24 | MYC_22102868_ChIP-Seq_BL_Human | 1.85408838 |
25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83058567 |
26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.81949389 |
27 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.80526709 |
28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.80521083 |
29 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80036176 |
30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.77265936 |
31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76870413 |
32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73640711 |
33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.73574827 |
34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72378194 |
35 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.68702051 |
36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.68080537 |
37 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.65970982 |
38 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.65921309 |
39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64248120 |
40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.64187343 |
41 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.64063231 |
42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63884517 |
43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.63673598 |
44 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.63151808 |
45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62410448 |
46 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.62008965 |
47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.61291887 |
48 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.60996116 |
49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.60201595 |
50 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57887527 |
51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.57759087 |
52 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56843204 |
53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54331710 |
54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.53804431 |
55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53428518 |
56 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.51650049 |
57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.51000286 |
58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49309906 |
59 | * MAF_26560356_Chip-Seq_TH1_Human | 1.48410240 |
60 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.48239820 |
61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47533166 |
62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47279806 |
63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47069908 |
64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46372859 |
65 | MYB_26560356_Chip-Seq_TH2_Human | 1.46208278 |
66 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43383634 |
67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42578161 |
68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42412812 |
69 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.42226011 |
70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.40797520 |
71 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40796179 |
72 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39393530 |
73 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.38592781 |
74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36025175 |
75 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.35123551 |
76 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.34909549 |
77 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.34645990 |
78 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33272184 |
79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.31781954 |
80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31648913 |
81 | MYB_26560356_Chip-Seq_TH1_Human | 1.31084231 |
82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.30289745 |
83 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29184492 |
84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28471577 |
85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27387223 |
86 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.27054090 |
87 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26818506 |
88 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25883842 |
89 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.25510405 |
90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24683462 |
91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.24602856 |
92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23723774 |
93 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23204655 |
94 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22917319 |
95 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.22577705 |
96 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22193855 |
97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20664394 |
98 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.20473694 |
99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18708848 |
100 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.17882606 |
101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17243435 |
102 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16921258 |
103 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16861608 |
104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16317797 |
105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15798766 |
106 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.15254233 |
107 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.14770189 |
108 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.14384686 |
109 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.12728561 |
110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12354435 |
111 | P68_20966046_ChIP-Seq_HELA_Human | 1.11755304 |
112 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.11420418 |
113 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09414748 |
114 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08546829 |
115 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08141403 |
116 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06066587 |
117 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05552999 |
118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.05531340 |
119 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05277556 |
120 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05063668 |
121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04329400 |
122 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03719452 |
123 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03420742 |
124 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02397471 |
125 | MAF_26560356_Chip-Seq_TH2_Human | 1.02291963 |
126 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00580694 |
127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00126682 |
128 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99446434 |
129 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99335284 |
130 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98361396 |
131 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97255514 |
132 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95921775 |
133 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95913943 |
134 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95422317 |
135 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95231539 |
136 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94985829 |
137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94772517 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.24905816 |
2 | MP0003806_abnormal_nucleotide_metabolis | 2.77444832 |
3 | MP0009785_altered_susceptibility_to | 2.74430045 |
4 | MP0000685_abnormal_immune_system | 2.65952579 |
5 | MP0005360_urolithiasis | 2.55339986 |
6 | MP0003436_decreased_susceptibility_to | 2.55094164 |
7 | MP0002166_altered_tumor_susceptibility | 2.28025019 |
8 | MP0005058_abnormal_lysosome_morphology | 2.23167748 |
9 | MP0003724_increased_susceptibility_to | 2.11784267 |
10 | MP0005025_abnormal_response_to | 2.10743648 |
11 | MP0008438_abnormal_cutaneous_collagen | 2.08398254 |
12 | MP0006082_CNS_inflammation | 2.06163352 |
13 | MP0005671_abnormal_response_to | 2.06141583 |
14 | MP0005000_abnormal_immune_tolerance | 1.96447188 |
15 | MP0002148_abnormal_hypersensitivity_rea | 1.94784903 |
16 | MP0002452_abnormal_antigen_presenting | 1.91148233 |
17 | MP0002419_abnormal_innate_immunity | 1.90701864 |
18 | MP0003693_abnormal_embryo_hatching | 1.88127005 |
19 | MP0002006_tumorigenesis | 1.87654993 |
20 | MP0002396_abnormal_hematopoietic_system | 1.84009191 |
21 | MP0002139_abnormal_hepatobiliary_system | 1.81280233 |
22 | MP0001800_abnormal_humoral_immune | 1.80761396 |
23 | MP0001853_heart_inflammation | 1.80705872 |
24 | MP0003763_abnormal_thymus_physiology | 1.78201985 |
25 | MP0000372_irregular_coat_pigmentation | 1.78168379 |
26 | MP0003303_peritoneal_inflammation | 1.77584147 |
27 | MP0002420_abnormal_adaptive_immunity | 1.76563523 |
28 | MP0001819_abnormal_immune_cell | 1.76105723 |
29 | MP0000858_altered_metastatic_potential | 1.74503915 |
30 | MP0002723_abnormal_immune_serum | 1.73909631 |
31 | MP0001790_abnormal_immune_system | 1.73080676 |
32 | MP0005387_immune_system_phenotype | 1.73080676 |
33 | MP0008007_abnormal_cellular_replicative | 1.72702521 |
34 | MP0002405_respiratory_system_inflammati | 1.68684706 |
35 | MP0009333_abnormal_splenocyte_physiolog | 1.68515033 |
36 | MP0002132_abnormal_respiratory_system | 1.67588766 |
37 | MP0000490_abnormal_crypts_of | 1.63852496 |
38 | MP0002398_abnormal_bone_marrow | 1.57991605 |
39 | MP0004957_abnormal_blastocyst_morpholog | 1.57071465 |
40 | MP0003183_abnormal_peptide_metabolism | 1.56796040 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.55979868 |
42 | MP0001545_abnormal_hematopoietic_system | 1.55979868 |
43 | MP0000604_amyloidosis | 1.54541531 |
44 | MP0010155_abnormal_intestine_physiology | 1.51309220 |
45 | MP0010352_gastrointestinal_tract_polyps | 1.51286583 |
46 | MP0003191_abnormal_cellular_cholesterol | 1.50591297 |
47 | MP0005464_abnormal_platelet_physiology | 1.49816523 |
48 | MP0000716_abnormal_immune_system | 1.44816297 |
49 | MP0005451_abnormal_body_composition | 1.44402048 |
50 | MP0000371_diluted_coat_color | 1.44369511 |
51 | MP0003186_abnormal_redox_activity | 1.44324670 |
52 | MP0000689_abnormal_spleen_morphology | 1.44261286 |
53 | MP0001873_stomach_inflammation | 1.43131102 |
54 | MP0003300_gastrointestinal_ulcer | 1.43113425 |
55 | MP0006054_spinal_hemorrhage | 1.42625990 |
56 | MP0001533_abnormal_skeleton_physiology | 1.40611790 |
57 | MP0001845_abnormal_inflammatory_respons | 1.39590776 |
58 | MP0002722_abnormal_immune_system | 1.39327953 |
59 | MP0004947_skin_inflammation | 1.38671235 |
60 | MP0010307_abnormal_tumor_latency | 1.37250684 |
61 | MP0009840_abnormal_foam_cell | 1.35796163 |
62 | MP0003448_altered_tumor_morphology | 1.35578506 |
63 | MP0004808_abnormal_hematopoietic_stem | 1.34607917 |
64 | MP0002429_abnormal_blood_cell | 1.32923026 |
65 | MP0001764_abnormal_homeostasis | 1.28160522 |
66 | MP0005365_abnormal_bile_salt | 1.27027276 |
67 | MP0002877_abnormal_melanocyte_morpholog | 1.24367357 |
68 | MP0003656_abnormal_erythrocyte_physiolo | 1.24182444 |
69 | MP0003705_abnormal_hypodermis_morpholog | 1.23801244 |
70 | MP0002653_abnormal_ependyma_morphology | 1.22119807 |
71 | MP0000343_altered_response_to | 1.21746004 |
72 | MP0000465_gastrointestinal_hemorrhage | 1.20515851 |
73 | MP0008469_abnormal_protein_level | 1.19343745 |
74 | MP0000015_abnormal_ear_pigmentation | 1.18890508 |
75 | MP0005023_abnormal_wound_healing | 1.17275779 |
76 | MP0003077_abnormal_cell_cycle | 1.14983002 |
77 | MP0003172_abnormal_lysosome_physiology | 1.14607440 |
78 | MP0005085_abnormal_gallbladder_physiolo | 1.13661451 |
79 | MP0003075_altered_response_to | 1.13604102 |
80 | MP0002019_abnormal_tumor_incidence | 1.11979237 |
81 | MP0008260_abnormal_autophagy | 1.11674937 |
82 | MP0010094_abnormal_chromosome_stability | 1.11092489 |
83 | MP0001958_emphysema | 1.09605150 |
84 | MP0005174_abnormal_tail_pigmentation | 1.09358232 |
85 | MP0003566_abnormal_cell_adhesion | 1.06674846 |
86 | MP0005319_abnormal_enzyme/_coenzyme | 1.06491572 |
87 | MP0009278_abnormal_bone_marrow | 1.05956114 |
88 | MP0000703_abnormal_thymus_morphology | 1.05374168 |
89 | MP0002095_abnormal_skin_pigmentation | 1.02110330 |
90 | MP0004147_increased_porphyrin_level | 1.00527494 |
91 | MP0005257_abnormal_intraocular_pressure | 0.99886316 |
92 | MP0001542_abnormal_bone_strength | 0.98998618 |
93 | MP0002933_joint_inflammation | 0.98890093 |
94 | MP0004782_abnormal_surfactant_physiolog | 0.98437810 |
95 | MP0008875_abnormal_xenobiotic_pharmacok | 0.97440320 |
96 | MP0000609_abnormal_liver_physiology | 0.94503946 |
97 | MP0005075_abnormal_melanosome_morpholog | 0.92164380 |
98 | MP0003111_abnormal_nucleus_morphology | 0.90584582 |
99 | MP0003828_pulmonary_edema | 0.90413692 |
100 | MP0003195_calcinosis | 0.88228809 |
101 | MP0009643_abnormal_urine_homeostasis | 0.88110212 |
102 | MP0005310_abnormal_salivary_gland | 0.88065973 |
103 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87183794 |
104 | MP0004883_abnormal_blood_vessel | 0.85122971 |
105 | MP0002277_abnormal_respiratory_mucosa | 0.84054535 |
106 | MP0003866_abnormal_defecation | 0.83590157 |
107 | MP0002138_abnormal_hepatobiliary_system | 0.83079880 |
108 | MP0001348_abnormal_lacrimal_gland | 0.82942675 |
109 | MP0009764_decreased_sensitivity_to | 0.82516808 |
110 | MP0003011_delayed_dark_adaptation | 0.79394539 |
111 | MP0009379_abnormal_foot_pigmentation | 0.79324424 |
112 | MP0000681_abnormal_thyroid_gland | 0.79227685 |
113 | MP0005164_abnormal_response_to | 0.78550112 |
114 | MP0003786_premature_aging | 0.77619384 |
115 | MP0003453_abnormal_keratinocyte_physiol | 0.77572321 |
116 | MP0002163_abnormal_gland_morphology | 0.76898768 |
117 | MP0009765_abnormal_xenobiotic_induced | 0.76735050 |
118 | MP0005390_skeleton_phenotype | 0.76555664 |
119 | MP0003638_abnormal_response/metabolism_ | 0.76507438 |
120 | MP0006036_abnormal_mitochondrial_physio | 0.75929415 |
121 | MP0008058_abnormal_DNA_repair | 0.75286956 |
122 | MP0001663_abnormal_digestive_system | 0.74691396 |
123 | MP0003279_aneurysm | 0.73634568 |
124 | MP0004510_myositis | 0.73191622 |
125 | MP0000313_abnormal_cell_death | 0.73101007 |
126 | MP0009763_increased_sensitivity_to | 0.72572512 |
127 | MP0000477_abnormal_intestine_morphology | 0.72036006 |
128 | MP0002075_abnormal_coat/hair_pigmentati | 0.71855888 |
129 | MP0003329_amyloid_beta_deposits | 0.71213646 |
130 | MP0005379_endocrine/exocrine_gland_phen | 0.70232558 |
131 | MP0000350_abnormal_cell_proliferation | 0.69479629 |
132 | MP0000358_abnormal_cell_content/ | 0.69091610 |
133 | MP0002254_reproductive_system_inflammat | 0.68873358 |
134 | MP0002998_abnormal_bone_remodeling | 0.68814527 |
135 | MP0005408_hypopigmentation | 0.68685161 |
136 | MP0003795_abnormal_bone_structure | 0.68663734 |
137 | MP0000750_abnormal_muscle_regeneration | 0.68526532 |
138 | MP0002118_abnormal_lipid_homeostasis | 0.68044629 |
139 | MP0001756_abnormal_urination | 0.66439139 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.25230446 |
2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.25230446 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.25230446 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.58374136 |
5 | Recurrent abscess formation (HP:0002722) | 3.97678350 |
6 | Vacuolated lymphocytes (HP:0001922) | 3.97054553 |
7 | Eczematoid dermatitis (HP:0000976) | 3.96754369 |
8 | Thrombocytosis (HP:0001894) | 3.74716117 |
9 | Myositis (HP:0100614) | 3.48569545 |
10 | Abnormality of macrophages (HP:0004311) | 3.41748004 |
11 | Stomatitis (HP:0010280) | 3.41151606 |
12 | Nasal polyposis (HP:0100582) | 3.31236774 |
13 | Recurrent bacterial skin infections (HP:0005406) | 3.30394964 |
14 | Interstitial pulmonary disease (HP:0006530) | 3.11705876 |
15 | Abnormality of the nasal mucosa (HP:0000433) | 3.10090282 |
16 | Increased cerebral lipofuscin (HP:0011813) | 3.08121578 |
17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.94320541 |
18 | Dysostosis multiplex (HP:0000943) | 2.92390176 |
19 | Reticulocytopenia (HP:0001896) | 2.91423199 |
20 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.87716496 |
21 | Abnormal number of erythroid precursors (HP:0012131) | 2.82231818 |
22 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.82058621 |
23 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.80616126 |
24 | J-shaped sella turcica (HP:0002680) | 2.79057189 |
25 | Vertebral compression fractures (HP:0002953) | 2.78773606 |
26 | IgM deficiency (HP:0002850) | 2.77124597 |
27 | Recurrent fungal infections (HP:0002841) | 2.73407803 |
28 | Reduced antithrombin III activity (HP:0001976) | 2.71816740 |
29 | Poor head control (HP:0002421) | 2.64928340 |
30 | Chronic otitis media (HP:0000389) | 2.62384112 |
31 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61215579 |
32 | Mucopolysacchariduria (HP:0008155) | 2.61215579 |
33 | Retrobulbar optic neuritis (HP:0100654) | 2.59926308 |
34 | Optic neuritis (HP:0100653) | 2.59926308 |
35 | Autoimmune thrombocytopenia (HP:0001973) | 2.58760697 |
36 | Generalized aminoaciduria (HP:0002909) | 2.56185459 |
37 | Disinhibition (HP:0000734) | 2.56042828 |
38 | Recurrent bronchitis (HP:0002837) | 2.54248331 |
39 | Mediastinal lymphadenopathy (HP:0100721) | 2.53758841 |
40 | Abnormality of iron homeostasis (HP:0011031) | 2.53757510 |
41 | Petechiae (HP:0000967) | 2.52534516 |
42 | Abnormality of T cell physiology (HP:0011840) | 2.50896765 |
43 | Prolonged neonatal jaundice (HP:0006579) | 2.45654025 |
44 | Multiple enchondromatosis (HP:0005701) | 2.44829394 |
45 | Upper motor neuron abnormality (HP:0002127) | 2.42680557 |
46 | Cardiomegaly (HP:0001640) | 2.38603898 |
47 | Mutism (HP:0002300) | 2.37342904 |
48 | Orchitis (HP:0100796) | 2.36272440 |
49 | Recurrent viral infections (HP:0004429) | 2.34673615 |
50 | Beaking of vertebral bodies (HP:0004568) | 2.34160138 |
51 | Loss of speech (HP:0002371) | 2.31106786 |
52 | Recurrent skin infections (HP:0001581) | 2.30381623 |
53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28395975 |
54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28395975 |
55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28395975 |
56 | Encephalitis (HP:0002383) | 2.26118133 |
57 | Abnormality of the anterior horn cell (HP:0006802) | 2.25341510 |
58 | Degeneration of anterior horn cells (HP:0002398) | 2.25341510 |
59 | Obstructive lung disease (HP:0006536) | 2.24548206 |
60 | Chronic obstructive pulmonary disease (HP:0006510) | 2.24548206 |
61 | Protrusio acetabuli (HP:0003179) | 2.21794192 |
62 | Pustule (HP:0200039) | 2.19849552 |
63 | Cervical subluxation (HP:0003308) | 2.19197054 |
64 | Abnormality of T cells (HP:0002843) | 2.18533578 |
65 | Type I transferrin isoform profile (HP:0003642) | 2.18341008 |
66 | Albinism (HP:0001022) | 2.17845194 |
67 | Purpura (HP:0000979) | 2.17784775 |
68 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.17283950 |
69 | Agammaglobulinemia (HP:0004432) | 2.13620045 |
70 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.10651471 |
71 | IgG deficiency (HP:0004315) | 2.10097685 |
72 | Pallor (HP:0000980) | 2.09955520 |
73 | Hematochezia (HP:0002573) | 2.08832978 |
74 | Eosinophilia (HP:0001880) | 2.08467742 |
75 | Microretrognathia (HP:0000308) | 2.06749838 |
76 | Granulocytopenia (HP:0001913) | 2.06495214 |
77 | Abnormal protein glycosylation (HP:0012346) | 2.06422704 |
78 | Abnormal glycosylation (HP:0012345) | 2.06422704 |
79 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.06422704 |
80 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.06422704 |
81 | Amyloidosis (HP:0011034) | 2.04987350 |
82 | Hemoptysis (HP:0002105) | 2.04484675 |
83 | Cellulitis (HP:0100658) | 2.04264815 |
84 | Abnormal hemoglobin (HP:0011902) | 2.02819214 |
85 | Periodontitis (HP:0000704) | 2.02503542 |
86 | 3-Methylglutaconic aciduria (HP:0003535) | 2.02024595 |
87 | Episodic fever (HP:0001954) | 2.02014656 |
88 | Leukocytosis (HP:0001974) | 2.01500451 |
89 | Lymphopenia (HP:0001888) | 2.00998371 |
90 | Entropion (HP:0000621) | 1.99866758 |
91 | * Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.99703834 |
92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99292245 |
93 | Thoracic kyphosis (HP:0002942) | 1.98847252 |
94 | Panhypogammaglobulinemia (HP:0003139) | 1.98227887 |
95 | Hyperammonemia (HP:0001987) | 1.97373773 |
96 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.96954260 |
97 | Recurrent cutaneous fungal infections (HP:0011370) | 1.96954260 |
98 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.96447689 |
99 | Basal ganglia calcification (HP:0002135) | 1.96359536 |
100 | Pulmonary infiltrates (HP:0002113) | 1.96204074 |
101 | Poikiloderma (HP:0001029) | 1.96104509 |
102 | Recurrent pneumonia (HP:0006532) | 1.95070613 |
103 | Gingivitis (HP:0000230) | 1.94939353 |
104 | Hypergammaglobulinemia (HP:0010702) | 1.94749379 |
105 | Systemic lupus erythematosus (HP:0002725) | 1.93061540 |
106 | Combined immunodeficiency (HP:0005387) | 1.91797082 |
107 | Hepatic necrosis (HP:0002605) | 1.91458633 |
108 | Ankle contracture (HP:0006466) | 1.87315164 |
109 | Severe combined immunodeficiency (HP:0004430) | 1.87035430 |
110 | Meningitis (HP:0001287) | 1.86383989 |
111 | Gastrointestinal infarctions (HP:0005244) | 1.86258974 |
112 | Nausea (HP:0002018) | 1.86067598 |
113 | Ragged-red muscle fibers (HP:0003200) | 1.85847939 |
114 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.84770268 |
115 | Abnormality of B cell number (HP:0010975) | 1.84521862 |
116 | B lymphocytopenia (HP:0010976) | 1.84521862 |
117 | Autoimmune hemolytic anemia (HP:0001890) | 1.84490417 |
118 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.83328344 |
119 | Selective tooth agenesis (HP:0001592) | 1.83235767 |
120 | Urticaria (HP:0001025) | 1.82183023 |
121 | Deformed sella turcica (HP:0002681) | 1.80833683 |
122 | Increased muscle lipid content (HP:0009058) | 1.80406037 |
123 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.80298821 |
124 | Aplastic anemia (HP:0001915) | 1.80176048 |
125 | Spontaneous hematomas (HP:0007420) | 1.79632172 |
126 | Recurrent lower respiratory tract infections (HP:0002783) | 1.78830711 |
127 | Abnormality of the prostate (HP:0008775) | 1.78724134 |
128 | Increased serum ferritin (HP:0003281) | 1.78577629 |
129 | Vasculitis (HP:0002633) | 1.78155909 |
130 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78125948 |
131 | Prolonged bleeding time (HP:0003010) | 1.75619010 |
132 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.75537886 |
133 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.75537886 |
134 | Cutaneous melanoma (HP:0012056) | 1.75492045 |
135 | Osteomyelitis (HP:0002754) | 1.75461774 |
136 | Micronodular cirrhosis (HP:0001413) | 1.75069967 |
137 | Macrocytic anemia (HP:0001972) | 1.74908493 |
138 | Anorexia (HP:0002039) | 1.74904014 |
139 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74781259 |
140 | Dicarboxylic aciduria (HP:0003215) | 1.74781259 |
141 | Trismus (HP:0000211) | 1.74009697 |
142 | Hepatosplenomegaly (HP:0001433) | 1.73835576 |
143 | Abnormal platelet function (HP:0011869) | 1.73795255 |
144 | Impaired platelet aggregation (HP:0003540) | 1.73795255 |
145 | Abnormality of eosinophils (HP:0001879) | 1.73646963 |
146 | Progressive neurologic deterioration (HP:0002344) | 1.73074547 |
147 | Hepatocellular necrosis (HP:0001404) | 1.72915518 |
148 | Abnormality of alanine metabolism (HP:0010916) | 1.70818402 |
149 | Hyperalaninemia (HP:0003348) | 1.70818402 |
150 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.70818402 |
151 | Skin rash (HP:0000988) | 1.68945880 |
152 | Axonal loss (HP:0003447) | 1.65103941 |
153 | Abnormality of the pleura (HP:0002103) | 1.64815231 |
154 | Hypokinesia (HP:0002375) | 1.63494210 |
155 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.62202370 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BUB1 | 2.65395095 |
2 | BLK | 2.64574816 |
3 | TRIB3 | 2.52394710 |
4 | MAP4K1 | 2.50053070 |
5 | NME2 | 2.39029226 |
6 | ERN1 | 2.37444427 |
7 | TBK1 | 2.37037325 |
8 | FLT3 | 2.32068671 |
9 | PIM2 | 2.29474174 |
10 | PKN2 | 2.14625930 |
11 | RIPK4 | 2.09931489 |
12 | EIF2AK1 | 2.05981699 |
13 | IRAK4 | 2.05732773 |
14 | TLK1 | 2.05600014 |
15 | TESK2 | 2.01766067 |
16 | KIT | 1.92296484 |
17 | WEE1 | 1.88560479 |
18 | ZAP70 | 1.83586768 |
19 | IRAK3 | 1.82086025 |
20 | TYK2 | 1.81762410 |
21 | ACVR1B | 1.79922931 |
22 | CDK19 | 1.79611999 |
23 | STK16 | 1.76298675 |
24 | KDR | 1.75282135 |
25 | ARAF | 1.74317753 |
26 | JAK3 | 1.72894494 |
27 | RPS6KA4 | 1.68918122 |
28 | NEK9 | 1.66311335 |
29 | IKBKE | 1.57104517 |
30 | BCKDK | 1.54680027 |
31 | LRRK2 | 1.53667802 |
32 | SCYL2 | 1.53607842 |
33 | TESK1 | 1.51085731 |
34 | TEC | 1.47446353 |
35 | MAP3K10 | 1.46235954 |
36 | TAOK2 | 1.40287024 |
37 | MAP3K11 | 1.39202662 |
38 | EIF2AK3 | 1.37248277 |
39 | FGFR4 | 1.36810403 |
40 | MAP3K13 | 1.35617668 |
41 | SIK3 | 1.33526973 |
42 | EEF2K | 1.33120727 |
43 | FES | 1.32078469 |
44 | BTK | 1.29111438 |
45 | MST1R | 1.27745951 |
46 | PAK4 | 1.26300431 |
47 | TGFBR2 | 1.25901277 |
48 | CSF1R | 1.24585027 |
49 | MAP3K1 | 1.21223890 |
50 | DYRK3 | 1.20660182 |
51 | EPHB1 | 1.16360845 |
52 | TNK2 | 1.14418897 |
53 | TGFBR1 | 1.10883581 |
54 | ILK | 1.09577066 |
55 | TXK | 1.09135058 |
56 | PIM1 | 1.07156810 |
57 | IKBKB | 1.06528139 |
58 | MAP2K3 | 1.04362106 |
59 | MAPKAPK3 | 1.04026167 |
60 | TAOK1 | 1.01659470 |
61 | BRSK2 | 0.97620624 |
62 | JAK1 | 0.96649938 |
63 | RPS6KB2 | 0.95037606 |
64 | STK10 | 0.94870228 |
65 | MAP4K2 | 0.94200370 |
66 | DYRK1B | 0.91864097 |
67 | NLK | 0.91238452 |
68 | ADRBK2 | 0.88900531 |
69 | VRK2 | 0.83052856 |
70 | NEK2 | 0.82394980 |
71 | SYK | 0.80130349 |
72 | CHUK | 0.78153415 |
73 | PRKD2 | 0.78009333 |
74 | MAP3K8 | 0.76536404 |
75 | LYN | 0.76090702 |
76 | FGFR3 | 0.75664181 |
77 | MAP3K14 | 0.74368512 |
78 | IRAK2 | 0.73923784 |
79 | IRAK1 | 0.73390990 |
80 | CDK6 | 0.73103119 |
81 | LCK | 0.72891506 |
82 | CDK8 | 0.72550260 |
83 | PASK | 0.72116403 |
84 | GRK7 | 0.72056432 |
85 | MAP2K6 | 0.69680932 |
86 | CAMKK2 | 0.68093110 |
87 | BMPR1B | 0.67177251 |
88 | FGR | 0.65691565 |
89 | MAP3K12 | 0.64829951 |
90 | GRK6 | 0.63571393 |
91 | CDK4 | 0.62307748 |
92 | ITK | 0.60711066 |
93 | EIF2AK2 | 0.60460048 |
94 | PRPF4B | 0.59759699 |
95 | PDPK1 | 0.59696014 |
96 | HCK | 0.58694830 |
97 | KSR2 | 0.57643141 |
98 | CSK | 0.56972219 |
99 | CDK9 | 0.55485050 |
100 | RPS6KA6 | 0.55402002 |
101 | VRK1 | 0.54709524 |
102 | CDK7 | 0.54643006 |
103 | ABL2 | 0.53967739 |
104 | JAK2 | 0.53822230 |
105 | RPS6KL1 | 0.53534280 |
106 | RPS6KC1 | 0.53534280 |
107 | DAPK3 | 0.51763357 |
108 | SIK2 | 0.51534900 |
109 | AURKB | 0.51348974 |
110 | MAP2K2 | 0.50884909 |
111 | YES1 | 0.50121915 |
112 | MAP3K5 | 0.50110579 |
113 | EPHA3 | 0.49631394 |
114 | MAP2K4 | 0.48232064 |
115 | MAPKAPK2 | 0.47974347 |
116 | MARK2 | 0.47493835 |
117 | MAPK11 | 0.46782877 |
118 | RPS6KA5 | 0.46281628 |
119 | MAP3K3 | 0.44963343 |
120 | MOS | 0.44025831 |
121 | MARK3 | 0.43740574 |
122 | BRAF | 0.43661532 |
123 | BMX | 0.42825172 |
124 | BMPR2 | 0.42508433 |
125 | PRKCD | 0.42269794 |
126 | ATR | 0.40856739 |
127 | PRKG2 | 0.40716824 |
128 | LIMK1 | 0.40316040 |
129 | ABL1 | 0.40202568 |
130 | MATK | 0.39569395 |
131 | PLK1 | 0.38966638 |
132 | MST4 | 0.38751177 |
133 | RPS6KA2 | 0.38590209 |
134 | SIK1 | 0.38082573 |
135 | TAOK3 | 0.37352524 |
136 | PDK1 | 0.36614612 |
137 | PTK6 | 0.34380116 |
138 | STK4 | 0.34257219 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.18228990 |
2 | Ribosome_Homo sapiens_hsa03010 | 3.18041924 |
3 | Proteasome_Homo sapiens_hsa03050 | 2.38204301 |
4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17759829 |
5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.03096653 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02843335 |
7 | Sulfur relay system_Homo sapiens_hsa04122 | 1.98642491 |
8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.90050202 |
9 | Base excision repair_Homo sapiens_hsa03410 | 1.88378889 |
10 | Mismatch repair_Homo sapiens_hsa03430 | 1.85527467 |
11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.75477532 |
12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.75052162 |
13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72755477 |
14 | Legionellosis_Homo sapiens_hsa05134 | 1.71470181 |
15 | Spliceosome_Homo sapiens_hsa03040 | 1.67567015 |
16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.67522588 |
17 | Measles_Homo sapiens_hsa05162 | 1.67089832 |
18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.60683483 |
19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60499230 |
20 | Lysosome_Homo sapiens_hsa04142 | 1.55292637 |
21 | RNA polymerase_Homo sapiens_hsa03020 | 1.53642769 |
22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.49640816 |
23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.47169585 |
24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46632696 |
25 | Homologous recombination_Homo sapiens_hsa03440 | 1.43659746 |
26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.43462590 |
27 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.40452634 |
28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40050198 |
29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37652295 |
30 | Shigellosis_Homo sapiens_hsa05131 | 1.34861340 |
31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.33716987 |
32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28814567 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27603475 |
34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26157659 |
35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25802208 |
36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.24858216 |
37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24699486 |
38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24031145 |
39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.22525334 |
40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.21872216 |
41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.19861110 |
42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.19318744 |
43 | Cell cycle_Homo sapiens_hsa04110 | 1.17505187 |
44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.15908277 |
45 | Protein export_Homo sapiens_hsa03060 | 1.15719572 |
46 | Malaria_Homo sapiens_hsa05144 | 1.15197329 |
47 | Pertussis_Homo sapiens_hsa05133 | 1.14304099 |
48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12371481 |
49 | Apoptosis_Homo sapiens_hsa04210 | 1.10992917 |
50 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.09310927 |
51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.09195906 |
52 | Allograft rejection_Homo sapiens_hsa05330 | 1.08810350 |
53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06070115 |
54 | RNA transport_Homo sapiens_hsa03013 | 1.03380136 |
55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03168721 |
56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03054704 |
57 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02833253 |
58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02803952 |
59 | Tuberculosis_Homo sapiens_hsa05152 | 1.01488130 |
60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.99350860 |
61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99317110 |
62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98426269 |
63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.97692402 |
64 | Influenza A_Homo sapiens_hsa05164 | 0.97101505 |
65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94771996 |
66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.94402813 |
67 | Hepatitis B_Homo sapiens_hsa05161 | 0.94166547 |
68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92388063 |
69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92058752 |
70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91978606 |
71 | Peroxisome_Homo sapiens_hsa04146 | 0.91654987 |
72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90742745 |
73 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90661543 |
74 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89218279 |
75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88160790 |
76 | Asthma_Homo sapiens_hsa05310 | 0.87866844 |
77 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.87117262 |
78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86754583 |
79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.85033187 |
80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84954245 |
81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83223196 |
82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.82384026 |
83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82242521 |
84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81972683 |
85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81758700 |
86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80674695 |
87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80405565 |
88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79013750 |
89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78857573 |
90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78610062 |
91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78580460 |
92 | Salmonella infection_Homo sapiens_hsa05132 | 0.75118361 |
93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72583808 |
94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70615106 |
95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70412538 |
96 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70243799 |
97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68930152 |
98 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66091325 |
99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64928816 |
100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63460186 |
101 | Phagosome_Homo sapiens_hsa04145 | 0.62975201 |
102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62736965 |
103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62457257 |
104 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61529936 |
105 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60090824 |
106 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59964260 |
107 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58809609 |
108 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.56385421 |
109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56350169 |
110 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56268477 |
111 | Hepatitis C_Homo sapiens_hsa05160 | 0.55924727 |
112 | Bladder cancer_Homo sapiens_hsa05219 | 0.55853410 |
113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55338805 |
114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53219748 |
115 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52786528 |
116 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52155974 |
117 | RNA degradation_Homo sapiens_hsa03018 | 0.51259850 |
118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51230212 |
119 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49893350 |
120 | Purine metabolism_Homo sapiens_hsa00230 | 0.49662799 |
121 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48258175 |
122 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47008288 |
123 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44929078 |
124 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44267115 |
125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42674183 |
126 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42266789 |
127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41459241 |
128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41073320 |
129 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40601747 |
130 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38477255 |
131 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37534011 |
132 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35317673 |
133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34824536 |
134 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33614410 |
135 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32591069 |
136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30239359 |
137 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.30164396 |